ZMapp, experimental Ebola drug, falls short in clinical trial that couldn't find enough new patients

Thursday, October 13, 2016 - 06:52 in Health & Medicine

ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it. Among 36 patients who were randomly assigned to receive ZMapp in addition to the standard therapy available...

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net